Humble+ Cannabis Solutions signs 2-year agreement to serve as exclusive sales representation for Wyld in Canada

 Humble & Fume Inc. (CNSX: HMBL), a leading North American distributor of cannabis and cannabis accessories, announced today that its subsidiary Humble+ Cannabis Solutions (“HCS”) has entered into an exclusive sales representation agreement with Galaxie Brands Corporation (“Galaxie”), a subsidiary of The Green Organic Dutchman Holdings Ltd. (“TGOD”) for the commercialization and distribution of Wyld cannabis edibles in Canada.

A small industry player outperforms its larger peers in 2021 and is the logical investment choice before the cannabis revolution happens.

Canada often has little choice but to bend to the heftier market forces of its neighbor to the south. The cannabis business was an exception after Ottawa legalized weed in 2018 and gave Canadian companies a lead. They've been angling for a stake in the larger U.S. market. But they need to act soon to make the most of the remaining early legalization buzz.

There were about $2 billion in cannabis sales in Canada in 2020, according to Bernstein analysts. That pales beside $17.5 billion in legal sales in the United States, where pot remains illegal at the federal level. Even without a change in that situation, Bernstein expects the American market will be worth some $40 billion a year by 2026.

Best Canadian Cannabis Stocks To Close 2021

Are you looking for top marijuana stocks to watch for 2022? In December most of the best cannabis stocks to invest in have declined to the lowest price points seen this year. As we head into 2022 the cannabis sector has sustained declines that could be an opportunity for new cannabis investors in 2022. One area that has been hit hard by the delays with federal cannabis reform is Canadian marijuana stocks.

This popular Canadian pot company might be inviting trouble.

As with any evolving industry, the marijuana industry also suffers from volatility. The Canadian industry, in particular, has faced several headwinds since it legalized medical and recreational cannabis. However, amid all the challenges, a few of the cannabis players, like Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB), stood out as the dominant players.

With the 2018 Cannabis Act legalizing THC for medical purposes, the popularity of CBD products has reached an all-time high.

And rightly so, since this cannabinoid does wonders for people suffering from chronic pain, insomnia, stress, and more. Seeing the skyrocketing demand for the best CBD oil in Canada, it is no surprise that the market is full of options.

Cannabis has been legalized in Canada for a little over three years now. Since then, cannabis has become an everyday part of Canadian life in multiple aspects. Whether it be through recreational use, medical use, or through a business, it’s become just as prevalent as alcohol and tobacco.

So how exactly has cannabis impacted daily life of Canadians?

Recreational use is one of the most obvious ways cannabis has become part of Canadian society. 23% of Canadians reported having used cannabis in 2020. Most of those were younger adults, with 36% of users being aged 18-24 and 38% of users being 25-34.

In a landmark decision, three Canadians struggling with mental health conditions were granted access to psilocybin-assisted psychotherapy by the federal Minister of Health Jean-Yves Duclos recently. The exemption comes following a wait of 283 days and was aided by B.C.-based TheraPsil.

Auxly Cannabis Group Inc. (TSX - XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is thrilled to announce that the Company received four awards for its popular consumer brands Back Forty, Kolab Project and Dosecann at the second annual Kind Awards – tied for the most of any Licensed Producer. These awards are published in Kind Magazine and recognize the very best in Canadian cannabis, as determined by a panel of nearly 250 budtenders across Canada.